Gerald Birch
Director of Finance/CFO at Colabs International Corp.
Profile
Gerald Birch is a Member of the Florida Board of Accountancy.
He is also the Chief Financial Officer at Colabs International Corp.
Mr. Birch has an undergraduate degree from York University.
Gerald Birch active positions
Companies | Position | Start |
---|---|---|
Colabs International Corp.
Colabs International Corp. Pharmaceuticals: MajorHealth Technology Colabs International Corp. is a pharmaceutical company that develops formulations and medicines. The company’s targeted epidermal-drug delivery system which is identified as QuantaSphere Technology for cosmeceuticals, fragrances, antibacterial, anti-viral sanitizers, cleaners, and topical pharmacology. It also offers sunscreen, pest repellents, and sanitizers, soap distribution for the firm’s Klenskin products internationally. Its QuantaSphere Technology formulations provide proprietary, epidermal therapeutic effects and also blends consumer needs for a healthy lifestyle with targeted, eco-friendly, multi-tasking products. The company was founded by Laura Cohen and Lisa Leblanc on August 5, 2008 and is headquartered in Huntington Beach, CA. | Director of Finance/CFO | 2010-12-31 |
Florida Board of Accountancy | Corporate Officer/Principal | - |
Training of Gerald Birch
York University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Florida Board of Accountancy | Government |
Colabs International Corp.
Colabs International Corp. Pharmaceuticals: MajorHealth Technology Colabs International Corp. is a pharmaceutical company that develops formulations and medicines. The company’s targeted epidermal-drug delivery system which is identified as QuantaSphere Technology for cosmeceuticals, fragrances, antibacterial, anti-viral sanitizers, cleaners, and topical pharmacology. It also offers sunscreen, pest repellents, and sanitizers, soap distribution for the firm’s Klenskin products internationally. Its QuantaSphere Technology formulations provide proprietary, epidermal therapeutic effects and also blends consumer needs for a healthy lifestyle with targeted, eco-friendly, multi-tasking products. The company was founded by Laura Cohen and Lisa Leblanc on August 5, 2008 and is headquartered in Huntington Beach, CA. | Health Technology |
- Stock Market
- Insiders
- Gerald Birch